Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CDC25A | P30304 | 2/20 | 0.50 |
| ▸ | CDC25B | P30305 | 2/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TST | Q16762 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Xyloquinone SCHEMBL49964 | 0.83 | PLK1 (0.60) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL17581103 | 0.77 | — | — | |
| SCHEMBL22805 | 0.77 | MAPT (0.46) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL7897027 | 0.77 | ALDH1A1 (0.41) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL14507720 | 0.75 | ALDH1A1 (0.44) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL11025815 | 0.73 | MAPT (0.50) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL14507718 | 0.72 | PLK1 (0.50) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL2137325 | 0.71 | ALDH1A1 (0.48) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL755506 | 0.71 | ALDH1A1 (0.48) | ALDH1A1MAPTMEN1MAPK1BLM | |
| SCHEMBL9653457 | 0.71 | MAPT (0.41) | ALDH1A1MAPTMEN1MAPK1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0460996-B1 | Keratinic fibres dyeing process with an aminoindol associated with a quinone derivative | OREAL (FR) | 1994-09-14 | — | — | EP | claimed |
| US-5180400-A | METHOD FOR DYEING KERATINOUS FIBRES USING AN AMINOINDOLE IN COMBINATION WITH A QUINONE DERIVATIVE | L'OREAL (FR) | 1993-01-19 | — | — | US | claimed |
| EP-0460996-A1 | Keratinic fibres dyeing process with an aminoindol associated with a quinone derivative | L'OREAL (FR) | 1991-12-11 | — | — | EP | claimed |
| EP-0376776-A2 | Process for dyeing keratinous fibres with hydroxyindole associated with quinone and 1,4-benzoquinone | L'OREAL (FR) | 1990-07-04 | — | — | EP | claimed |
| US-20220175954-A1 | HYPOXIA-INDUCING CRYOGELS | NORTHEASTERN UNIVERSITY | 2022-06-09 | — | — | US | disclosed |
| US-20180159141-A1 | Non-Platinum Group Oxygen Reduction Reaction Catalysts | BATTELLE SAVANNAH RIVER ALLIANCE, LLC | 2018-06-07 | — | — | US | disclosed |
| US-20180159141-A1 | Non-Platinum Group Oxygen Reduction Reaction Catalysts | BATTELLE SAVANNAH RIVER ALLIANCE, LLC | 2018-06-07 | — | — | US | disclosed |
| WO-2010134580-A1 | METHOD FOR PRODUCING AROMATIC FLUORINE COMPOUND AND NOVEL COMPOUND | 静岡県公立大学法人 (JP) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010134580-A1 | METHOD FOR PRODUCING AROMATIC FLUORINE COMPOUND AND NOVEL COMPOUND | 静岡県公立大学法人 (JP) | 2010-11-25 | — | — | WO | disclosed |
| EP-1457813-B1 | An improved electrochromic medium capable of producing a pre-selected color | GENTEX CORP (US) | 2007-01-24 | — | — | EP | disclosed |
| EP-1457813-A2 | An improved electrochromic medium capable of producing a pre-selected color | Gentex Corporation (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-0972227-B1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORP (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-0460996-B1 | Keratinic fibres dyeing process with an aminoindol associated with a quinone derivative | OREAL (FR) | 1994-09-14 | — | — | EP | disclosed |
| EP-0603322-A1 | DYEING COMPOSITION BASED ON HYDROXYINDOLINE DERIVATIVES. | OREAL (FR) | 1994-06-29 | — | — | EP | disclosed |
| WO-1993005018-A1 | DYEING COMPOSITION BASED ON HYDROXYINDOLINE DERIVATIVES | L'OREAL (FR) | 1993-03-18 | — | — | WO | disclosed |
| US-5180400-A | METHOD FOR DYEING KERATINOUS FIBRES USING AN AMINOINDOLE IN COMBINATION WITH A QUINONE DERIVATIVE | L'OREAL (FR) | 1993-01-19 | — | — | US | disclosed |
| EP-0376776-B1 | PROCESS FOR DYEING KERATINOUS FIBRES WITH HYDROXYINDOLE ASSOCIATED WITH QUINONE AND 1,4-BENZOQUINONE | L'OREAL (FR) | 1992-09-23 | — | — | EP | disclosed |
| EP-0460996-A1 | Keratinic fibres dyeing process with an aminoindol associated with a quinone derivative | L'OREAL (FR) | 1991-12-11 | — | — | EP | disclosed |
| US-5053053-A | PROCESS FOR DYEING KERATINOUS FIBRES WITH A HYDROXYINDOLE IN COMBINATION WITH A QUINONE DERIVATIVE; AND NOVEL 1,4-BENZOQUINONES | L'OREAL (FR) | 1991-10-01 | — | — | US | disclosed |
| EP-0376776-A2 | Process for dyeing keratinous fibres with hydroxyindole associated with quinone and 1,4-benzoquinone | L'OREAL (FR) | 1990-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175954-A1 | HYPOXIA-INDUCING CRYOGELS | HIF1A, HYOU1, HIF1AN | ALDH1A1 2762/4885MAPT 3758/4885MEN1 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.